Director Hoppenot Herve sold 187,500 shares of INCY at $105.46, reducing holdings by -36.3% to 329,646 shares; stock at $108.26 current price.
Hoppenot Herve sold 187,500 shares (187.5K shares) at $105.46 on 2025-11-10 for $19,773,750.00 ($19.8M), reducing his position from 517,146 shares to 329,646 shares—a -36.3% reduction in holdings. The sale occurred when INCY stock was trading below its current price of $108.26, near the 52-week high of $108.26, after a 27.8% surge over the prior 30 days and 25.6% gain over 90 days. This substantial reduction in a director's position occurred amid strong recent price momentum and solid fundamentals (Revenue $1.4B, Net income $424.2M, Annual revenue growth +14.8%, P/E 17.89, Market cap $21.3B). The magnitude of the divestiture—representing more than one-third of prior holdings—warrants investor attention alongside the timing relative to recent equity appreciation.